A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons

Biochemical and Biophysical Research Communications

Volumn 335, Issue 1, 2005, Pages 220-226

  Iwano, Shunsuke ^a   Nukaya, Manabu ^a   Saito, Tetsuya ^a   Asanuma, Fumie ^a   Kamataki, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ABCA1; FAS; Luciferase assay; LXR; PAHs; Quantitative RT PCR; SCD; SREBP 1c

Indexed keywords

3 METHYLCHOLANTHRENE; ACYL COENZYME A DESATURASE; FATTY ACID SYNTHASE; LIVER X RECEPTOR; POLYCYCLIC AROMATIC HYDROCARBON; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; ENZYME INHIBITION; ENZYME REPRESSION; GENE CONTROL; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ARTERIOSCLEROSIS; BENZ(A)ANTHRACENES; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; POLYCYCLIC HYDROCARBONS, AROMATIC; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; RNA, SMALL INTERFERING; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 25144469686     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.062     Document Type: Article

References (29)

1. H.A. Hattemer-Frey, and C.C. Travis Benzo-a-pyrene: environmental partitioning and human exposure Toxicol. Ind. Health 7 1991 141 157
2. K.P. Miller, and K.S. Ramos Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons Drug Metab. Rev. 33 2001 1 35
3. M.W. Majesky, H.Y. Yang, E.P. Benditt, and M.R. Juchau Carcinogenesis and atherogenesis: differences in monooxygenase inducibility and bioactivation of benzo[a]pyrene in aortic and hepatic tissues of atherosclerosis-susceptible versus resistant pigeons Carcinogenesis 4 1983 647 652
4. B. Paigen, P.A. Holmes, A. Morrow, and D. Mitchell Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors Cancer Res. 46 1986 3321 3324
5. A. Izzotti, S. De Flora, G.L. Petrilli, J. Gallagher, M. Rojas, K. Alexandrov, H. Bartsch, and J. Lewtas Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts Cancer Epidemiol. Biomarkers Prev. 4 1995 105 110
6. J.S. Ross, N.E. Stagliano, M.J. Donovan, R.E. Breitbart, and G.S. Ginsburg Atherosclerosis and cancer: common molecular pathways of disease development and progression Ann. N.Y. Acad. Sci. 947 2001 271 292
7. S.A. Salama, W.W. Au, G.C. Hunter, R.G. Sheahan, O.A. Badary, A.B. Abdel-Naim, and F.M. Hamada Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers Environ. Mol. Mutagen. 40 2002 153 160
8. M.S. Denison, L.M. Vella, and A.B. Okey Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Species difference in molecular properties of the receptors from mouse and rat hepatic cytosols J. Biol. Chem. 261 1986 3987 3995
9. Y. Shimizu, Y. Nakatsuru, M. Ichinose, Y. Takahashi, H. Kume, J. Mimura, Y. Fujii-Kuriyama, and T. Ishikawa Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor Proc. Natl. Acad. Sci. USA 97 2000 779 782
10. E.K. Silbergeld, and T.A. Gasiewicz Dioxins and the Ah receptor Am. J. Ind. Med. 16 1989 455 474
11. O. Hankinson The aryl hydrocarbon receptor complex Annu. Rev. Pharmacol. Toxicol. 35 1995 307 340
12. B.A. Janowski, P.J. Willy, T.R. Devi, J.R. Falck, and D.J. Mangelsdorf An oxysterol signalling pathway mediated by the nuclear receptor LXRα Nature 383 1996 728 738
13. J.M. Lehmann, S.A. Kliewer, L.B. Moore, T.A. Smith-Oliver, B.B. Oliver, J.L. Su, S.S. Sundseth, D.A. Winegar, D.E. Blanchard, T.A. Spencer, and T.M. Willson Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway J. Biol. Chem. 272 1997 3137 3140
14. J.J. Repa, and D.J. Mangelsdorf The role of orphan nuclear receptors in the regulation of cholesterol homeostasis Annu. Rev. Cell Dev. Biol. 16 2000 459 481
15. J.J. Repa, S.D. Turley, J.A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R.A. Heyman, J.M. Dietschy, and D.J. Mangelsdorf Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers Science 289 2000 1524 1529
16. A.R. Tall, and N. Wang Tangier disease as a test of the reverse cholesterol transport hypothesis J. Clin. Invest. 106 2000 1205 1207
17. M.S. Brown, and J.L. Goldstein The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340
18. S.B. Joseph, B.A. Laffitte, P.H. Patel, M.A. Watson, K.E. Matsukuma, R. Walczak, J.L. Collins, T.F. Osborne, and P. Tontonoz Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors J. Biol. Chem. 277 2002 11019 11025
19. P.A. Edwards, D. Tabor, H.R. Kast, and A. Venkateswaran Regulation of gene expression by SREBP and SCAP Biochim. Biophys. Acta 1529 2000 103 113
20. M. Miyazaki, Y.C. Kim, M.P. Gray-Keller, A.D. Attie, and J.M. Ntambi The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1 J. Biol. Chem. 275 2000 30132 30138
21. P.J. Willy, K. Umesono, E.S. Ong, R.M. Evans, R.A. Heyman, and D.J. Mangelsdorf LXR, a nuclear receptor that defines a distinct retinoid response pathway Genes Dev. 9 1995 1033 1045
22. D.E. Tabor, J.B. Kim, B.M. Spiegelman, and P.A. Edwards Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2 J. Biol. Chem. 274 1999 20603 20610
23. N.S. Lee, T. Dohjima, G. Bauer, H. Li, M.J. Li, A. Ehsani, P. Salvaterra, and J. Rossi Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nat. Biotechnol. 5 2002 500 505
24. P.J. Paddison, A.A. Caudy, E. Bernstein, G.J. Hannon, and D.S. Conklin Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells Genes Dev. 16 2002 948 958
25. C.P. Paul, P.D. Good, I. Winer, and D.R. Engelke Effective expression of small interfering RNA in human cells Nat. Biotechnol. 5 2002 505 508
26. T.R. Brummelkamp, R. Bernards, and R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550 553
27. G. Sui, C. Soohoo, B. Affarel, F. Gay, Y. Shi, W.C. Forrester, and Y. Shi A DNA vector-based RNAi technology to suppress gene expression in mammalian cells Proc. Natl. Acad. Sci. USA 99 2002 5515 5520
28. J. McNeish, R.J. Aiello, D. Guyot, T. Turi, C. Gabe, C. Aldinger, K.L. Hoppe, M.L. Roach, L.J. Royer, J. de Wet, C. Broccardo, G. Chimini, and O.L. Francone High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1 Proc. Natl. Acad. Sci. USA 97 2000 4245 4250
29. J.J. Repa, J.M. Dietschy, and S.D. Turley Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte J. Lipid Res. 43 2002 1864 1874